- The FDA’s Center for Biologics Evaluation and Research (CBER) will convene a virtual meeting of the Vaccines and Related Biological Products Advisory Committee on June 10
- The virtual meeting will provide a status update on its approach to expand the emergency use authorization (EUA) of COVID-19 vaccines to those aged 12 – 15 years, the regulator said in a press release.
- The meeting will also discuss the data required to support a EUA and a biologics license application (BLA) for COVID-19 vaccines to children less than 12 years old.
- Any specific product will not be discussed, the agency said.
- “We want to ensure that the public has a clear understanding of our expectations for the data and information needed to support requests for emergency use authorization and biologics license applications for vaccines intended to prevent COVID-19 in this pediatric age range,” FDA said.
Colony Bankcorp Q3 EPS $0.30 Misses $0.37 Estimate, Sales $29.04M Miss $31.69M Estimate
Colony Bankcorp (NASDAQ:CBAN) reported quarterly earnings of $0.30 per share which missed the analyst consensus estimate of $0.37 by 18.92 percent. This is a 47.37 percent decrease over earnings of $0.57 per share from
